This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50239241
rdf:type
wikibase:Item
schema:description
vitenskapelig artikkel naučni članak บทความทางวิทยาศาสตร์ επιστημονικό άρθρο artículo científico publicado en 2016 научная статья 2016年学术文章 scientific article published on 24 May 2016 articolo scientifico artigo científico 2016년 논문 2016年学术文章 ২৪ মে ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2016年學術文章 vitskapeleg artikkel tudományos cikk научни чланак vetenskaplig artikel videnskabelig artikel vědecký článek artikulong pang-agham artikel ilmiah wetenschappelijk artikel научни чланак 2016年學術文章 article científic article scientific научна статия tieteellinen artikkeli 2016年学术文章 scientific article published on 24 May 2016 articol științific مقالة علمية نشرت في 24 مايو 2016 bilimsel makale artigo científico article scientifique 2016年学术文章 2016年學術文章 teaduslik artikkel wissenschaftlicher Artikel scientific article published on 24 May 2016 2016年学术文章 מאמר מדעי სამეცნიერო სტატია artikull shkencor наукова стаття, опублікована в травні 2016 bài báo khoa học artykuł naukowy 2016 nî lūn-bûn 2016年の論文 2016年学术文章 2016年學術文章 artículu científicu vedecký článok scienca artikolo artigo científico 2016年學術文章 мақолаи илмӣ
p:P577
wds:Q50239241-1A3E66F7-B551-441D-BF5B-3D2E8C40591B
wdt:P577
2016-05-24T00:00:00Z
p:P2860
wds:Q50239241-B91662DD-17D9-4647-B8A2-DD5112F53229 wds:Q50239241-BA1F6DE2-DC00-4082-ADA3-90943D72C57D wds:Q50239241-6E0E7E0B-B89D-4529-976F-09CCBA189B92 wds:Q50239241-91BD28AC-C4ED-4802-8D57-7DE8F0014366 wds:Q50239241-77F900BC-E2F6-4175-96A4-921CB5771E70 wds:Q50239241-82F73A60-AE60-42F9-BD04-5972C0612115
wdt:P2860
wd:Q38131380 wd:Q38533346 wd:Q34408882 wd:Q35848236 wd:Q34450381 wd:Q36839385
p:P2093
wds:Q50239241-2248837F-3C74-4A7A-AA7C-19425E809CDC wds:Q50239241-2D6F8806-4974-4A17-861E-5747B4F59D6A wds:Q50239241-580FE199-75C9-4970-B193-2A7B8EBD7D26 wds:Q50239241-40CF562A-56F3-4AB9-948C-102498DD2C38 wds:Q50239241-52416F06-006B-48F5-A9AA-C0A72018CD73 wds:Q50239241-6E90A476-571D-470F-BCA3-6F672E07C314 wds:Q50239241-6F1B69B2-3386-4F0B-9179-929A657AC9C2 wds:Q50239241-6104E5DB-B812-4B79-8DC5-AE78F7619CCD wds:Q50239241-91EF308B-EEDA-4938-963C-AD1F7438790A wds:Q50239241-BA45E99C-5470-47A9-B7C4-69E53DEF8C03 wds:Q50239241-C27F5E0D-6B5B-4FB9-98A5-63AE71B0F721 wds:Q50239241-E88DF42D-132B-438A-8FCC-B8AF4E2B33CA wds:Q50239241-F41F8E0B-8185-412B-98E0-F74137112274
wdt:P2093
Ana M García-Alonso Carmen García-Garay Natividad R Montes Valentin Cabañas-Perianes Adela Blasco-Mogorrón Manuel Muro José A Campillo Lourdes Gimeno Adela Periago Mercedes Berenguer José M Bolarin María V Martínez-Sánchez Anna Mrowiec
rdfs:label
Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Circulating aberrant plasma cells allows risk stratification of patients with myeloma.
skos:prefLabel
Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Circulating aberrant plasma cells allows risk stratification of patients with myeloma.
schema:name
Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Circulating aberrant plasma cells allows risk stratification of patients with myeloma.
p:P50
wds:Q50239241-E8D5B7C2-DF12-4A06-8895-2E791A0ECF88 wds:Q50239241-7B951F89-A87F-45B4-8D09-7C573B0DADF2
wdt:P50
wd:Q86220283 wd:Q57061547
p:P1476
wds:Q50239241-CA92F89A-3A6B-4CDC-8808-9EA2DB7B98E9
wdt:P1476
Circulating aberrant plasma cells allows risk stratification of patients with myeloma
p:P304
wds:Q50239241-F25D4910-8DCF-4EE6-86DD-0187BEE9BA06
wdt:P304
E353-E355
p:P31
wds:Q50239241-8C930718-79B1-42C4-9C04-32699CF634E3
wdt:P31
wd:Q13442814
p:P698
wds:Q50239241-A2AD9C8C-1AB2-4518-BF78-10425BC75C94
wdtn:P698
n11:27220360
wdt:P698
27220360
p:P1433
wds:Q50239241-5C9FA4E1-A5DD-4307-82B6-A096631A882E
wdt:P1433
wd:Q4744246
p:P433
wds:Q50239241-214D1F3D-CA9B-4133-BC16-659A6FE882DB
p:P478
wds:Q50239241-1D3F043C-9567-4C3C-B8C6-28923A0720BF
wdt:P433
9
wdt:P478
91
p:P356
wds:Q50239241-A2DCC6E4-466F-43DE-A49C-5E2FAB936222
wdtn:P356
n9:AJH.24431
wdt:P356
10.1002/AJH.24431